Plasma proprotein convertase subtilisin kexin type 9 is a heritable trait of familial combined hyperlipidemia - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Clinical Science Année : 2011

Plasma proprotein convertase subtilisin kexin type 9 is a heritable trait of familial combined hyperlipidemia

Marleen Mj van Greevenbroek
  • Fonction : Auteur
Jason Troutt
  • Fonction : Auteur
Angela Bonner Freeman
  • Fonction : Auteur
Ake Lu
  • Fonction : Auteur
Nicolaas C Schaper
  • Fonction : Auteur
Robert John Konrad
  • Fonction : Auteur
Coen D.A. Stehouwer
  • Fonction : Auteur

Résumé

Objective: To study the relation between circulating proprotein convertase subtilisin kexin type 9 (PCSK9) and familial combined hyperlipidemia (FCHL) and - when positive - to determine the strength of its heritability. Methods: Plasma PCSK9 levels were measured in FCHL patients (n=45), normolipidemic relatives (n=139) and their spouses (n=72). In addition, eleven FCHL patients were treated with atorvastatin to study the response in PCSK9 levels. Results: PCSK9 levels were higher in FCHL patients versus normolipidemic relatives and spouses: 96.1 versus 78.7 and 82.0 ng/mL, p=0.004 and p=0.002, respectively. PCSK9 was significantly associated with both triglycerides and apolipoprotein B levels (p<0.001). The latter relation was accounted for by LDL-apoliprotein B (r=0.31, p=0.02), not by VLDL-apolipoprotein B (r=0.09, p=0.49) in a subgroup of subjects (n=59). Heritability calculations for PCSK9 using SOLAR and FCOR yielded estimates of 67-84%, respectively (p<0.0001). PCSK9 increased from 122 to 150 ng/mL in eleven FCHL patients treated with atorvastatin 40mg once daily for 8 weeks (p=0.018). Conclusions: Plasma PCSK9 is a heritable trait associated with both FCHL diagnostic hallmarks. These results combined with the significant rise in PCSK9 levels after statin therapy warrant further studies to unravel the exact role of PCSK9 in the pathogenesis and treatment of this highly prevalent genetic dyslipidemia.

Mots clés

Fichier principal
Vignette du fichier
PEER_stage2_10.1042%2FCS20110129.pdf (368.2 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-00717078 , version 1 (12-07-2012)

Identifiants

Citer

Martijn C.G.J. Brouwers, Marleen Mj van Greevenbroek, Jason Troutt, Angela Bonner Freeman, Ake Lu, et al.. Plasma proprotein convertase subtilisin kexin type 9 is a heritable trait of familial combined hyperlipidemia. Clinical Science, 2011, 121 (9), pp.397-403. ⟨10.1042/CS20110129⟩. ⟨hal-00717078⟩

Collections

PEER
22 Consultations
160 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More